Money is drastically needed for Cancer Trials

Only 3 percent of adult patients participate in trials, the rest discouraged for many reasons, including excessive administrative and regulatory burden and sharply decreased federal funding for clinical trials.

Federally funded research through the National Institutes of Health has played a critical role in every major advance in cancer treatment over the last 50 years. This funding has not increased a penny for more than a decade, leaving N.I.H. federal research funds with a 23 percent loss this year alone, when adjusted for biomedical inflation. Promising research is now going unfunded, and new studies are being scaled back, leaving fewer patients with the opportunity to participate in clinical trials.